Safety and efficacy of bexarotene in patients with relapsing-remitting multiple sclerosis (CCMR One): a randomised, double-blind, placebo-controlled, parallel-group, phase 2a study
-
Published:2021-09
Issue:9
Volume:20
Page:709-720
-
ISSN:1474-4422
-
Container-title:The Lancet Neurology
-
language:en
-
Short-container-title:The Lancet Neurology
Author:
Brown J William LORCID, Cunniffe Nick GORCID, Prados FerranORCID, Kanber BarisORCID, Jones Joanne LORCID, Needham EdwardORCID, Georgieva ZoyaORCID, Rog DavidORCID, Pearson Owen RORCID, Overell JamesORCID, MacManus DavidORCID, Samson Rebecca SORCID, Stutters JonathanORCID, ffrench-Constant CharlesORCID, Gandini Wheeler-Kingshott Claudia A MORCID, Moran CarlaORCID, Flynn Paul D, Michell Andrew W, Franklin Robin J MORCID, Chandran SiddharthanORCID, Altmann Daniel R, Chard Declan TORCID, Connick PeterORCID, Coles Alasdair JORCID
Subject
Neurology (clinical)
Cited by
55 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
|
|